BMB Reports

생화학분자생물학회 (Korean Society for Biochemistry and Molecular Biology)
권호 표지
DOI QR코드

DOI QR Code

Berberine suppresses in vitro migration of human aortic smooth muscle cells through the inhibitions of MMP-2/9, u-PA, AP-1, and NF-κB

  • Liu, Su-Jian (Department of Interventional Therapy of Peripheral Vascular, Aerospace Center Hospital) ;
  • Yin, Cai-Xia (The Center of Anesthesia and Operation Room, Chinese PLA General Hospital) ;
  • Ding, Ming-Chao (Department of Interventional Therapy of Peripheral Vascular, Aerospace Center Hospital) ;
  • Xia, Shao-You (The Center of Anesthesia and Operation Room, Chinese PLA General Hospital) ;
  • Shen, Qin-Min (Department of Vascular Surgery, Beijing Aerospace General Hospital) ;
  • Wu, Ji-Dong (Department of Vascular Surgery, Beijing Aerospace General Hospital)
  • 투고 : 2013.08.14
  • 심사 : 2013.11.07
  • 발행 : 2014.07.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Berberine, a type of isoquinoline alkaloid isolated from Chinese medicinal herbs, has been reported to have various pharmacological activities. Studies have demonstrated that berberine has beneficial effects on vascular remodeling and alleviates restenosis after vascular injury. However, its mechanism of action on vascular smooth muscle cell migration is not fully understood. We therefore investigated the effect of berberine on human aortic smooth muscle cell (HASMC) migration. Boyden chamber assay was performed to show that berberine inhibited HASMC migration dose-dependently. Real-time PCR and Western blotting analyses showed that levels of matrix metalloproteinase (MMP)-2, MMP-9, and urokinase-type plasminogen activator (u-PA) were reduced by berberine at both the mRNA and protein levels. Western blotting assay further confirmed that activities of c-Fos, c-Jun, and NF-${\kappa}B$ were significantly attenuated. These results suggest that berberine effectively inhibited HASMC migration, possibly by down-regulating MMP-2, MMP-9, and u-PA; and interrupting AP-1 and NF-${\kappa}B$ mediated signaling pathways.

키워드

참고문헌

  1. Mills, B., Robb, T. and Larson, D. F. (2012) Intimal hyperplasia: slow but deadly. Perfusion 27, 520-528. https://doi.org/10.1177/0267659112452316
  2. Bennett, M. R. (2003) In-stent stenosis: pathology and implications for the development of drug eluting stents. Heart 89, 218-224. https://doi.org/10.1136/heart.89.2.218
  3. Lowe, H. C., Oesterle, S. N. and Khachigian, L. M. (2002) Coronary in-stent restenosis: current status and future strategies. J. Am. Coll. Cardiol. 39, 183-193.
  4. Lafont, A. and Libby, P. (1998) The smooth muscle cell: sinner or saint in restenosis and the acute coronary syndromes? J. Am. Coll. Cardiol. 32, 283-285. https://doi.org/10.1016/S0735-1097(98)00216-2
  5. Gerthoffer, W. T. (2007) Mechanisms of vascular smooth muscle cell migration. Circ. Res. 100, 607-621. https://doi.org/10.1161/01.RES.0000258492.96097.47
  6. Siefert, S. A. and Sarkar, R. (2012) Matrix metalloproteinases in vascular physiology and disease. Vascular 20, 210-216. https://doi.org/10.1258/vasc.2011.201202
  7. Johnson, J. L., Dwivedi, A., Somerville, M., George, S. J. and Newby, A. C. (2011) Matrix metalloproteinase (MMP)-3 activates MMP-9 mediated vascular smooth muscle cell migration and neointima formation in mice. Arterioscler. Thromb. Vasc. Biol. 31, 30.
  8. Schiller, L. R. (1995) Review article: anti-diarrhoeal pharmacology and therapeutics. Aliment. Pharmacol. Ther. 9, 87-106.
  9. Hwang, J.-M., Kuo, H.-C., Tseng, T.-H., Liu, J.-Y. and Chu, C.-Y. (2006) Berberine induces apoptosis through a mitochondria/caspases pathway in human hepatoma cells. Arch. Toxicol. 80, 62-73. https://doi.org/10.1007/s00204-005-0014-8
  10. Mahata, S., Bharti, A. C., Shukla, S., Tyagi, A., Husain, S. A. and Das, B. C. (2011) Berberine modulates AP-1 activity to suppress HPV transcription and downstream signaling to induce growth arrest and apoptosis in cervical cancer cells. Mol. Cancer. 10, 39. https://doi.org/10.1186/1476-4598-10-39
  11. Li, X. K., Motwani, M., Tong, W., Bornmann, W. and Schwartz, G. K. (2000) Huanglian, A chinese herbal extract, inhibits cell growth by suppressing the expression of cyclin B1 and inhibiting CDC2 kinase activity in human cancer cells. Mol. Pharmacol. 58, 1287-1293. https://doi.org/10.1124/mol.58.6.1287
  12. Nishino, H., Kitagawa, K., Fujiki, H. and Iwashima, A. (1986) Berberine sulfate inhibits tumor-promoting activity of teleocidin in two-stage carcinogenesis on mouse skin. Oncology 43, 131-134. https://doi.org/10.1159/000226349
  13. Pan, G. Y., Huang, Z. J., Wang, G. J., Fawcett, J. P., Liu, X. D., Zhao, X. C., Sun, J. G. and Xie, Y. Y. (2003) The antihyperglycaemic activity of berberine arises from a decrease of glucose absorption. Planta Med. 69, 632-636. https://doi.org/10.1055/s-2003-41121
  14. Leng, S. H., Lu, F. E. and Xu, L. J. (2004) Therapeutic effects of berberine in impaired glucose tolerance rats and its influence on insulin secretion. Acta Pharmacol. Sin. 25, 496-502.
  15. Yin, J., Hu, R., Chen, M., Tang, J., Li, F., Yang, Y. and Chen, J. (2002) Effects of berberine on glucose metabolism in vitro. Metabolism 51, 1439-1443. https://doi.org/10.1053/meta.2002.34715
  16. Hong, Y., Hui, S. S., Chan, B. T. and Hou, J. (2003) Effect of berberine on catecholamine levels in rats with experimental cardiac hypertrophy. Life Sci. 72, 2499-2507. https://doi.org/10.1016/S0024-3205(03)00144-9
  17. Hong, Y., Hui, S. C., Chan, T. Y. and Hou, J. Y. (2002) Effect of berberine on regression of pressure-overload induced cardiac hypertrophy in rats. Am. J. Chin. Med. 30, 589-599. https://doi.org/10.1142/S0192415X02000612
  18. Zeng, X. H., Zeng, X. J. and Li, Y. Y. (2003) Efficacy and safety of berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am. J. Cardiol. 92, 173-176. https://doi.org/10.1016/S0002-9149(03)00533-2
  19. Lee, S., Lim, H.-J., Park, H.-Y., Lee, K.-S., Park, J.-H. and Jang, Y. (2006) Berberine inhibits rat vascular smooth muscle cell proliferation and migration in vitro and improves neointima formation after balloon injury in vivo: berberine improves neointima formation in a rat model. Atherosclerosis 186, 29-37. https://doi.org/10.1016/j.atherosclerosis.2005.06.048
  20. Liang, K.-W., Ting, C.-T., Yin, S.-C., Chen, Y.-T., Lin, S.-J., Liao, J. K. and Hsu, S.-L. (2006) Berberine suppresses MEK/ERK-dependent Egr-1 signaling pathway and inhibits vascular smooth muscle cell regrowth after in vitro mechanical injury. Biochem. Pharmacol. 71, 806-817. https://doi.org/10.1016/j.bcp.2005.12.028
  21. Chase, A. J. and Newby, A. C. (2003) Regulation of matrix metalloproteinase (matrixin) genes in blood vessels: a multi-step recruitment model for pathological remodelling. J. Vasc. Res. 40, 329-343. https://doi.org/10.1159/000072697
  22. Mason, D. P., Kenagy, R. D., Hasenstab, D., Bowen-Pope, D. F., Seifert, R. A., Coats, S., Hawkins, S. M. and Clowes, A. W. (1999) Matrix metalloproteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery. Circ. Res. 85, 1179-1185. https://doi.org/10.1161/01.RES.85.12.1179
  23. Nelson, A. R., Fingleton, B., Rothenberg, M. L. and Matrisian, L. M. (2000) Matrix metalloproteinases: biologic activity and clinical implications. J. Clin. Oncol. 18, 1135-1149.
  24. Redmond, E. M., Cahill, P. A., Hirsch, M., Wang, Y. N., Sitzmann, J. V. and Okada, S. S. (1999) Effect of pulse pressure on vascular smooth muscle cell migration: the role of urokinase and matrix metalloproteinase. Thromb. Haemost. 81, 293-300.
  25. Bond, M., Fabunmi, R. P., Baker, A. H. and Newby, A. C. (1998) Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-$\kappa{B}$. FEBS Lett. 435, 29-34. https://doi.org/10.1016/S0014-5793(98)01034-5
  26. Zhang, H.-W., Wang, X., Zong, Z.-H., Huo, X. and Zhang, Q. (2009) AP-1 inhibits expression of MMP-2/9 and its effects on rat smooth muscle cells. J. Surg. Res. 157, e31-e37. https://doi.org/10.1016/j.jss.2009.02.015
  27. Moon, S.-K., Kim, H.-M. and Kim, C.-H. (2004) PTEN induces G1 cell cycle arrest and inhibits MMP-9 expression via the regulation of NF-$\kappa{B}$ and AP-1 in vascular smooth muscle cells. Arch. Biochem. Biophys. 421, 267-276. https://doi.org/10.1016/j.abb.2003.11.007
  28. Suh, S.-J., Jin, U.-H., Choi, H.-J., Chang, H. W., Son, J.-K., Lee, S. H., Jeon, S.-J., Son, K.-H., Chang, Y.-C. and Lee, Y.-C. (2006) Cryptotanshinone from Salvia miltiorrhiza BUNGE has an inhibitory effect on TNF-$\alpha$-induced matrix metalloproteinase-9 production and HASMC migration via down-regulated NF-$\kappa{B}$ and AP-1. Biochem. Pharmacol. 72, 1680-1689. https://doi.org/10.1016/j.bcp.2006.08.013
  29. Shishodia, S., Potdar, P., Gairola, C. G. and Aggarwal, B. B. (2003) Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-$\kappa{B}$ activation through inhibition of $I\kappa{B}\alpha$ kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1. Carcinogenesis 24, 1269-1279. https://doi.org/10.1093/carcin/bgg078

피인용 문헌

  1. Berberine inhibits Chlamydia pneumoniae infection-induced vascular smooth muscle cell migration through downregulating MMP3 and MMP9 via PI3K vol.755, 2015, https://doi.org/10.1016/j.ejphar.2015.02.039
  2. Berberis Vulgarisand Berberine: An Update Review vol.30, pp.11, 2016, https://doi.org/10.1002/ptr.5693
  3. Effect of berberine on PPARα-NO signalling pathway in vascular smooth muscle cell proliferation induced by angiotensin IV vol.55, pp.1, 2017, https://doi.org/10.1080/13880209.2016.1257642
  4. Research advances in HMGN5 and cancer vol.37, pp.2, 2016, https://doi.org/10.1007/s13277-015-4693-3
  5. Berberine inhibits tumor necrosis factor-α-induced expression of inflammatory molecules and activation of nuclear factor-κB via the activation of AMPK in vascular endothelial cells vol.12, pp.4, 2015, https://doi.org/10.3892/mmr.2015.4061
  6. KSP inhibitor SB743921 induces death of multiple myeloma cells via inhibition of the NF-κB signaling pathway vol.48, pp.10, 2015, https://doi.org/10.5483/BMBRep.2015.48.10.015